Home
Finance & valuation

Finance & valuation

South Korea’s IP-backed lending market growth exceeds targets

Although heavy reliance on government-backed initiatives creates uncertain future for IP holders

‘Live or die’: LG Chem prepares to launch series of disputes as strategy pivots, reveals IP head

The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min

JS Held expands Ocean Tomo IP practice with new acquisition

The global scientific and engineering consultancy has bought TechPats, a patent-focused technical expert firm, at a time when an uncertain economy and declining number of M&As has led some companies to issue layoff notices to IP staff

Latest content

Five key takeaways from IPBC Europe

Returning from two action-packed days in London, IAM Deputy Editor Adam Houldsworth reflects on the surprising state of corporate UPC strategies, the rise of AI, FRAND fireworks and more

02 April 2022

Highlights from the final day of IPBC Europe 2022

Patent value, IP finance and the challenges of digitisation were just some of the subjects discussed in front of a sell-out audience in London yesterday

31 March 2022

Ocean Tomo acquired by global consulting firm J.S. Held

Two years after private equity buyout, the pioneering IP advisory firm led by Jim Malackowski changes hands again

30 March 2022

Korean university’s litigation debacle bolsters case for litigation funding transparency

KAIST’s dispute with its own licensing arm may be a problem of the university’s own making, but it underlines the opacity of modern patent litigation

26 March 2022

The brokered patent market in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

ROI’s latest report on sales activity and reflections on 10 years of market tracking

02 March 2022

The life science royalty sales market

Featured in Special Report 2022 Q1: Patent Dealmaking

Some of the highest-value deals in intellectual property today are taking place in the burgeoning marketplace for revenue streams linked to pharmaceutical products

02 March 2022

US patent assignments in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

Six things we learned about the transactions marketplace in a year that featured notable patent deals both big and small

02 March 2022

The brokered patent market in 2021

Featured in Secondary Market Activity

Richardson Oliver Insights highlights how the patent market has evolved to the point where it is not only a place to buy and sell assets.

02 March 2022

Fortress IP co-founder leaves the firm to explore new opportunities

I have nothing but good things to say about the company but it's time to move on and do something new, says Joseph Kessler

01 March 2022

More is being done than ever before to monetise neglected pharma IP

Roivant’s most recent spinout shows that it is still on the hunt for deprioritised life sciences patents

22 February 2022

Unlock unlimited access to all IAM content